Item 9A. Controls and Procedures
ITEM
9A. CONTROLS AND PROCEDURES
Our
management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e)
and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that
we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s
rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated
to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers,
or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
An
evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation
of our disclosure controls and procedures as of August 31, 2021. Based on our management’s evaluation under the framework in Internal
Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management concluded
that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in
the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified
in SEC rules and forms.
A
material weakness is a control deficiency, or combination of control deficiencies, such that there is a reasonable possibility that a
material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. We have identified
a lack of segregation of duties, a lack of audit committee or independent governance/oversight, and timely communication with vendors
to obtain invoices and record expenses and liabilities as material weaknesses in our internal controls over financial reporting as of
the end of the fiscal year ended August 31, 2021.
Such
officer also confirmed that there was no change in our internal control over financial reporting during the year August 31, 2021 that
has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
ITEM
9B. OTHER INFORMATION
None.
8 | Page
PART
III
ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The
name, age and titles of our executive officer and director are as follows:
Name
and Address of Executive
Officer
and/or Director
Age
Position
Low
Wai Koon
No 2, Jalan Rimba Riang 9/9,
Seksyen 9, Kota Damansara
47810 Petaling Jaya, Selangor, Malaysia
51
President,
Treasurer, Secretary and Director
(Principal
Executive, Financial and Accounting Officer)
Our
Director Low Wai Koon:
Held
his offices/positions since February 26, 2021 and is expected to hold said offices/positions until the next annual meeting of our stockholders.
The officers listed are our only officers and control persons.
Low
Wai Koon has acted as our President, Treasurer, Secretary and Director since February 26, 2021 .
Dr. Low, 50, is the founder of WKL Eco Earth Sdn Bhd. (“WKL”). Dr. Low has held senior management roles of WKL since 2017.
Prior to joining WKL, Dr. Low had over 15 years of working experience in the mechanical engineering sector. Dr. Low obtained an Honorary
Doctorate in Robotics Engineering Science and is a Honorary Fellow of the International Society of Professional Engineers, USA. Dr. Low
has never been in default with the bank or government and does not have any pending litigations or claims.
Dr.
Low owns 67.34% of the outstanding shares of our common stock. On February 26, 2021, Veniamin Minkov resigned as the former director,
Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Secretary and Treasurer of the Company. Veniamin
Minkov’s resignation as Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Secretary and Treasurer
was effective immediately. Veniamin Minkov’s resignation as a director become effective ten (10) days following the filing by the
Company of the Information Statement on Schedule 14f-1 with the United States Securities and Exchange Commission. Prior to Veniamin Minkov’s
resignation, he appointed Dr, Low as the Company’s Director and Chairman of the Board, Chief Executive Officer, Chief Financial
Officer, President, Secretary and Treasurer of the Company. There were no disagreements between Dr. Low and the Company on any matter
relating to the Company’s operations, policies or practices, which resulted in his resignation. Dr. Low’s previous experience,
qualifications, attributes or skills were not considered when he was appointed as our President, Chief Executive Officer, Treasurer,
Chief Financial Officer, Chief Accounting Officer, Secretary and member of our board of directors.
AUDIT
COMMITTEE
We
do not have an audit committee or audit committee financial expert. We do not have an audit committee financial expert because we believe
the cost related to retaining a financial expert at this time is prohibitive. Further, because we have limited operations, at the present
time, we believe the services of a financial expert are not warranted.
SIGNIFICANT
EMPLOYEES
Other
than our director, we do not expect any other individuals to make a significant contribution to our business.
9 | Page
ITEM
11. EXECUTIVE COMPENSATION
The
following tables set forth certain information about compensation paid, earned or accrued for services by our Executive Officer for the
years ended AUGUST 31, 2020 and AUGUST 31, 2021:
Summary
Compensation Table
Name
and
Principal
Position
Period
Salary
($)
Bonus
($)
Stock
Awards
($)
Option
Awards
($)
Non-Equity
Incentive Plan
Compensation
($)
All
Other
Compensation
($)
All
Other
Compensation
($)
Total
($)
Low
Wai Koon, President, Secretary and Treasurer
September
1, 2019 to August 31, 2020
-0-
-0-
-0-
-0-
-0-
-0-
-0-
-0-
September 1, 2020
to August 31, 2021
-0-
-0-
-0-
-0-
-0-
-0-
-0-
-0-
There
are no current employment agreements between the company and its officer.
There
are no annuity, pension or retirement benefits proposed to be paid to the officer or director or employees in the event of retirement
at normal retirement date pursuant to any presently existing plan provided or contributed to by the company or any of its subsidiaries,
if any.
CHANGE
OF CONTROL
As
of August 31, 2021, we had no pension plans or compensatory plans or other arrangements which provide compensation in the event of a
termination of employment or a change in our control.
ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The
following table sets forth information as of August 31, 2021 regarding the ownership of our common stock by each shareholder known by
us to be the beneficial owner of more than five percent of our outstanding shares of common stock, each director and all executive officers
and directors as a group. Except as otherwise indicated, each of the shareholders has sole voting and investment power with respect to
the shares of common stock beneficially owned.
Title
of Class
Name
and Address of
Beneficial
Owner
Amount
and Nature of
Beneficial
Ownership
Percent
of class
Common
Stock
Low
Wai Koon
No 2,
Jalan Rimba Riang 9/9,
Seksyen 9, Kota Damansara
47810 Petaling Jaya, Selangor, Malaysia
2,000,000
shares of common stock (direct)
67.34%
The
percent of class is based on 2,970,000 shares of common stock issued and outstanding as of August 31, 2020.
10 | Page
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
In
support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances or amounts paid in satisfaction
of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.
Since
February 17, 2017 (Inception) through February 28, 2021, the Company’s former sole officer and director, Veniamin Minkov, loaned
the Company $11,567 to pay for incorporation costs and operating expenses. The loan is non-interest bearing, due upon demand and unsecured.
Veniamin
Minkov, confirmed to the Board of Directors (“Board”) of the Company to forgive the loan extended by him to the Company amounting
to $11,567. The Company wrote off cash balance of $40 and carrying amount of a fixed asset of $185 against a loan from related party
of $11,567. The balance of the loan from related party and stock refund payable of $1,950 amounting to $13,292 were written off against
additional paid- in capital.
In
addition, pursuant to the terms of the Securities Purchase Agreement dated February 26, 2021, by and among Veniamin Minkov, the former
sole officer, director, and majority stockholder of the Company and Low Wai Koon (the “Agreement”), Veniamin Minkov warranted
that on the Effective Date (defined hereunder) the Company will have no assets and no debt of any kind including no outstanding tax liabilities
and that all existing contracts entered into by the Company shall be cancelled without liability.
During the
year ended August 31, 2021, a company related to Dr Low Wai Koon, the Company’s new sole officer and director, has paid fees on
behalf of the Company in view that the Company has yet to open new bank account in the United States of America after Change of Control
disclosed in Note 7 due to travel restrictions imposed as a result of Covid-19 pandemic. The amount due to related parties were provided
as unsecured obligations. The funds were used to pay audit and professional fees on behalf of the Company. The obligations bear no interest,
have no fixed term and are not evidenced by any written agreement. As of August 31, 2021, the balance in due to related party is $44,134.
ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The
following table presents the fees for professional audit services) for the audit of the Company’s annual financial statements for
the fiscal years ended August 31, 2021 and August 31, 2020 and fees billed for other services rendered by the auditors
during those periods. All services reflected in the following fee table were pre - approved, respectively, in accordance with
the policy of the Board.
August 31, 2021
August 31, 2020
Audit fees (1)
$ 20,000
$ 10,000
Audit-related fees
-
-
Tax fees
-
-
All other fees
-
-
Total Fees
$ 20,000
$ 10,000
Notes:
(1) Audit fees consist
of audit and review services, consent and review of documents filed with the SEC. For fiscal years ended August 31, 2021 and August
31, 2020, respectively.
In
its capacity, the Board pre-approves all audit (including audit-related) and permitted non-audit services to be performed by the independent
auditors. The Board will annually approve the scope and fee estimates for the year-end audit to be performed by the Company’s independent
auditors for the fiscal year. With respect to other permitted services, the Board pre-approves specific engagements, projects and categories
of services on a fiscal year basis, subject to the individual project and annual maximums. To date, the Company has not engaged its auditors
to perform any non-audit related services.
ITEM
15. EXHIBITS
The
following exhibits are filed as part of this Annual Report.
31.1
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
32.1
Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes- Oxley Act of 2002
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Document
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
11 | Page
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
UNEX
HOLDINGS INC.
Dated:
November 29, 2021
By:
/s/
Low Wai Koon
Low
Wai Koon, President and Chief
Executive Officer and Chief Financial Officer
12 | Page
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.